☰

How effective will the use of monoclonal antibody-based approaches be within asthma & COPD drug development and future commercial pipelines?

Pharmaceuticals & Biotechnology Editor |

How effective will the use of monoclonal antibody-based approaches be within asthma & COPD drug development and future commercial pipelines?

RECOMMENDED

Unlocking AI's Transformative Potential in Life Sciences
2024-11-07

From Patient Centricity to Patient Leadership: Pharma’s New Digital Engagement Frontier
2024-10-10

Transforming Healthcare Communications: The Role of AI and Human Interaction at Cymphony
2024-10-10

Navigating Customer Experience Innovations in Pharma and the HCP Experience
2024-09-06

Upcoming Events

Pharmaceutical Launch Excellence Summit

2 - 3 December, 2025
UK
Register Now | View Agenda | Learn More

SmartLab Exchange Europe

24 - 25 February 2026
Amsterdam
Register Now | View Agenda | Learn More

Pharma Contract Manufacturing

25 - 26 March 2026
Germany
Register Now | View Agenda | Learn More

MORE EVENTS